LY6K and cancer: Interestingly, Ly6K is a 'cancer-testis antigen' expressed at elevated levels in various cancers [78], and a promising target for anticancer vaccine production [79], thus establishing its general suitability as a vaccine antigen that might also prove useful in an immunocontraceptive formulation.